Home Healthcare Medical Devices Bioresorbable Coronary Scaffolds Market

Bioresorbable Coronary Scaffolds Market Size, Share & Trends Analysis Report By Type (Polymeric Scaffolds, Magnesium-based Scaffolds, Composite), By Application (Acute Coronary Syndrome, Chronic Coronary Syndrome), By End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Academic & Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 09, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Bioresorbable Coronary Scaffolds Market, By Type 2025-2034 (USD MILLION/ Units)
    1. Polymeric Scaffolds
    2. Magnesium-based Scaffolds
    3. Composite
  2. Bioresorbable Coronary Scaffolds Market, By Application 2025-2034 (USD MILLION/ Units)
    1. Acute Coronary Syndrome
    2. Chronic Coronary Syndrome
  3. Bioresorbable Coronary Scaffolds Market, By End User 2025-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Cardiac Centers
    3. Ambulatory Surgical Centers
    4. Academic & Research Institutes
  4. Regional Bioresorbable Coronary Scaffolds Market
    1. North America
      1. North America Bioresorbable Coronary Scaffolds Market By Type 2025-2034 (USD MILLION/ Units)
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
      2. North America Bioresorbable Coronary Scaffolds Market By Application 2025-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Chronic Coronary Syndrome
      3. North America Bioresorbable Coronary Scaffolds Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cardiac Centers
        3. Ambulatory Surgical Centers
        4. Academic & Research Institutes
      4. U.S.
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      5. Canada
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
    2. Europe
      1. Europe Bioresorbable Coronary Scaffolds Market By Type 2025-2034 (USD MILLION/ Units)
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
      2. Europe Bioresorbable Coronary Scaffolds Market By Application 2025-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Chronic Coronary Syndrome
      3. Europe Bioresorbable Coronary Scaffolds Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cardiac Centers
        3. Ambulatory Surgical Centers
        4. Academic & Research Institutes
      4. U.K.
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      5. Germany
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      6. France
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      7. Spain
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      8. Italy
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      9. Russia
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      10. Nordic
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      11. Benelux
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      12. Rest of Europe
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
    3. APAC
      1. APAC Bioresorbable Coronary Scaffolds Market By Type 2025-2034 (USD MILLION/ Units)
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
      2. APAC Bioresorbable Coronary Scaffolds Market By Application 2025-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Chronic Coronary Syndrome
      3. APAC Bioresorbable Coronary Scaffolds Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cardiac Centers
        3. Ambulatory Surgical Centers
        4. Academic & Research Institutes
      4. China
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      5. Korea
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      6. Japan
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      7. India
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      8. Australia
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      9. Taiwan
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      10. South East Asia
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      11. Rest of Asia-Pacific
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Bioresorbable Coronary Scaffolds Market By Type 2025-2034 (USD MILLION/ Units)
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
      2. Middle East and Africa Bioresorbable Coronary Scaffolds Market By Application 2025-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Chronic Coronary Syndrome
      3. Middle East and Africa Bioresorbable Coronary Scaffolds Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cardiac Centers
        3. Ambulatory Surgical Centers
        4. Academic & Research Institutes
      4. UAE
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      5. Turkey
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      6. Saudi Arabia
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      7. South Africa
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      8. Egypt
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      9. Nigeria
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      10. Rest of MEA
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
    5. LATAM
      1. LATAM Bioresorbable Coronary Scaffolds Market By Type 2025-2034 (USD MILLION/ Units)
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
      2. LATAM Bioresorbable Coronary Scaffolds Market By Application 2025-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Chronic Coronary Syndrome
      3. LATAM Bioresorbable Coronary Scaffolds Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cardiac Centers
        3. Ambulatory Surgical Centers
        4. Academic & Research Institutes
      4. Brazil
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      5. Mexico
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      6. Argentina
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      7. Chile
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      8. Colombia
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
      9. Rest of LATAM
        1. Polymeric Scaffolds
        2. Magnesium-based Scaffolds
        3. Composite
        4. Acute Coronary Syndrome
        5. Chronic Coronary Syndrome
        6. Hospitals
        7. Cardiac Centers
        8. Ambulatory Surgical Centers
        9. Academic & Research Institutes
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.